Showing results out of
EMBL Heidelberg researchers compared the effect of drugs on isolated bacteria versus those growing in communities. This is the first study showing that bacteria are more resilient when in community due to cross-protection strategies. This could help researchers design more efficient therapies.
SCIENCE & TECHNOLOGY2024
science-technology
Sponges lack muscles and neurons. Yet, they make coordinated movements. Scientists at EMBL Heidelberg have discovered that sponge movement is controlled by an ancient ‘relaxant-inflammatory’ response that is also present in vertebrate blood vessels. The findings shed light on sponge physiology…
SCIENCE & TECHNOLOGY2024
sciencescience-technology
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
A new paper from EMBL’s Savitski team and Typas group describes their work on E. coli and how it brings a greater understanding of the way genes function and interact.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL scientists identify drug targets in blood and organs
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Scientists develop technology to measure how ATP concentration affects protein solubility in cells
SCIENCE & TECHNOLOGY2019
sciencescience-technology
EMBL scientists uncover large solubility and thermal stability changes of proteins during the cell cycle
SCIENCE & TECHNOLOGY2018
sciencescience-technology
Scientists at EMBL and Cellzome develop technology to monitor the effects of drug treatments on protein degradation and synthesis
SCIENCE & TECHNOLOGY2018
sciencescience-technology
EMBL scientists create a turnover catalogue of almost 10.000 proteins from primary cells
SCIENCE & TECHNOLOGY2018
sciencescience-technology
Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases
SCIENCE & TECHNOLOGY2016
sciencescience-technology
New head of Proteomics Core Facility also runs stability proteomics lab
PEOPLE & PERSPECTIVES2016
people-perspectivesscience
No results found